A) Adjuvants that stimulate toll-like receptors.
B) Injecting pulsed dendritic cells back into the patient.
C) Introducing virus genes into the human genome.
D) Using a gene gun to deliver the vaccine.
E) Injection of plasmid DNA that expresses a viral antigen.